JP2013543850A5 - - Google Patents

Download PDF

Info

Publication number
JP2013543850A5
JP2013543850A5 JP2013538047A JP2013538047A JP2013543850A5 JP 2013543850 A5 JP2013543850 A5 JP 2013543850A5 JP 2013538047 A JP2013538047 A JP 2013538047A JP 2013538047 A JP2013538047 A JP 2013538047A JP 2013543850 A5 JP2013543850 A5 JP 2013543850A5
Authority
JP
Japan
Prior art keywords
prolyl
group
methyl
leucyl
amidinophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013538047A
Other languages
English (en)
Japanese (ja)
Other versions
JP6219720B2 (ja
JP2013543850A (ja
Filing date
Publication date
Priority claimed from CN201010535094.4A external-priority patent/CN102464701B/zh
Application filed filed Critical
Publication of JP2013543850A publication Critical patent/JP2013543850A/ja
Publication of JP2013543850A5 publication Critical patent/JP2013543850A5/ja
Application granted granted Critical
Publication of JP6219720B2 publication Critical patent/JP6219720B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013538047A 2010-11-08 2011-11-04 新規な化合物、その製造方法および用途 Active JP6219720B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201010535094.4A CN102464701B (zh) 2010-11-08 2010-11-08 一类新型化合物、其制备方法及用途
CN201010535094.4 2010-11-08
PCT/CN2011/081811 WO2012062187A1 (zh) 2010-11-08 2011-11-04 作为凝血酶抑制剂的脯氨酰胺衍生物、其制备方法及应用

Publications (3)

Publication Number Publication Date
JP2013543850A JP2013543850A (ja) 2013-12-09
JP2013543850A5 true JP2013543850A5 (cg-RX-API-DMAC7.html) 2014-12-11
JP6219720B2 JP6219720B2 (ja) 2017-10-25

Family

ID=46050404

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013538047A Active JP6219720B2 (ja) 2010-11-08 2011-11-04 新規な化合物、その製造方法および用途

Country Status (5)

Country Link
US (1) US9434760B2 (cg-RX-API-DMAC7.html)
EP (3) EP2639230A4 (cg-RX-API-DMAC7.html)
JP (1) JP6219720B2 (cg-RX-API-DMAC7.html)
CN (1) CN102464701B (cg-RX-API-DMAC7.html)
WO (1) WO2012062187A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103833827B (zh) * 2012-11-27 2016-08-03 上海医药工业研究院 一种酰胺类化合物、其药物组合物、制备方法及应用
MX389001B (es) * 2015-10-23 2025-03-20 Navitor Pharm Inc Moduladores de interacción de sestrina-gator2 y sus usos.
ES3040534T3 (en) 2017-04-26 2025-11-03 Navitor Pharm Inc Modulator of sestrin-gator2 interaction for use in the treatment of treatment-resistant depression
KR102836091B1 (ko) * 2018-04-26 2025-07-18 제리아 신야쿠 고교 가부시키 가이샤 디펩티드 및 이것을 함유하는 의약 조성물
WO2020086816A1 (en) 2018-10-24 2020-04-30 Navitor Pharmaceuticals, Inc. Polymorphic compounds and uses thereof
WO2020092139A1 (en) 2018-10-29 2020-05-07 Huahai Us Inc. Novel dipeptide compounds and uses thereof
WO2021007190A1 (en) * 2019-07-08 2021-01-14 Rezolute, Inc. Processes for preparing plasma kallikrein inhibitors
EP4010320A4 (en) 2019-08-06 2023-08-16 Biocryst Pharmaceuticals, Inc. Process-scale synthesis of a plasma kallikrein inhibitor
AU2020376950B2 (en) 2019-11-01 2026-06-11 Supernus Pharmaceuticals, Inc. Methods of treatment using an mTORC1 modulator
JP2026504578A (ja) * 2023-02-16 2026-02-05 浙江華海薬業股▲フン▼有限公司 ジペプチド類化合物の塩、ならびにその調製方法および使用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4101653A (en) 1974-11-08 1978-07-18 Mitsubishi Chemical Industries Limited N2 -arylsulfonyl-argininamides and the pharmaceutically acceptable salts thereof
CA1161431A (en) * 1979-05-11 1984-01-31 Lars G. Svendsen Tripeptide derivatives
HU178398B (en) 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
SE9103612D0 (sv) 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
US5583146A (en) * 1992-12-02 1996-12-10 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
AU1025795A (en) * 1994-01-27 1995-08-03 Mitsubishi Chemical Corporation Prolineamide derivatives
JP3840668B2 (ja) * 1994-01-27 2006-11-01 三菱化学株式会社 プロリンアミド誘導体
ZA951617B (en) 1994-03-04 1997-02-27 Lilly Co Eli Antithrombotic agents.
US5510369A (en) 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
FI973360L (fi) * 1995-02-17 1997-08-15 Basf Ag Uusia dipeptidisiä amidiineja trombiininestäjiksi
ES2186807T3 (es) 1995-10-24 2003-05-16 Merck & Co Inc Inhibidores de trombina.
FI105274B (fi) 1996-03-15 2000-07-14 Upm Kymmene Oy Menetelmä ei-hormonivaikutteisten, tyydyttymättömien kasvisteroidien hydraamiseksi ja käytetyn katalyytin regenerointi
WO1999037668A1 (de) * 1998-01-26 1999-07-29 Basf Aktiengesellschaft Thrombininhibitoren
CA2369378A1 (en) * 1999-04-09 2000-10-19 Basf Aktiengesellschaft Low-molecular inhibitors of complement proteases
DE10064797A1 (de) * 2000-12-22 2002-06-27 Knoll Ag Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon
HUP0304058A2 (hu) * 2001-01-30 2004-04-28 Bristol-Myers Squibb Company Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
WO2008076415A1 (en) * 2006-12-14 2008-06-26 Exelixis, Inc. Methods of using mek inhibitors

Similar Documents

Publication Publication Date Title
CA2437966C (en) 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
NO20061340L (no) Anvendelse av fumarsyrederivater for behandling av hjerteinsuffisiens og astma
US7105567B2 (en) 3-substituted urea derivatives and medicinal use thereof
JP2004508304A5 (cg-RX-API-DMAC7.html)
AU2002253009A1 (en) 4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical
JP2014516360A5 (cg-RX-API-DMAC7.html)
US6878707B2 (en) Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion
JP2016512822A5 (cg-RX-API-DMAC7.html)
JP2014515013A5 (cg-RX-API-DMAC7.html)
CZ2003892A3 (cs) Polyarylkarboxamidy jako činidla snižující hladinu lipidů
JP2012506852A5 (cg-RX-API-DMAC7.html)
JP2006509749A5 (cg-RX-API-DMAC7.html)
JP2010505906A5 (cg-RX-API-DMAC7.html)
HRP20161378T1 (hr) Dihidropiridon kao faktor xia inhibitora
JP2004503549A (ja) 生体等配電子性ベンズアミド誘導体およびそのアポb−100分泌阻害剤としての使用
KR101052204B1 (ko) 아포리포프로테인 b 분비 저해제로서의 n-아릴 피페리딘치환된 바이페닐카복스아미드
KR960704876A (ko) 혈소판 응집 저해 작용을 갖는 신규 화합물 (Novel Compound Having Platelet Aggregation Inhibitor Effect)
JP2010506910A5 (cg-RX-API-DMAC7.html)
WO2024155965A3 (en) Biomarkers for use in integrin inhibitor therapy
CA2667041A1 (en) N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression
NZ590315A (en) Fxa inhibitors with cyclic amidoxime or cyclic amidrazone as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
US10391076B2 (en) Anti-cancer agent comprising aminoacetonitrile compound as active ingredient
JP2003506432A (ja) カルボン酸アミド、その調製法及び医薬組成物としてのその使用
JP2019529553A (ja) 結晶形
RU2015145460A (ru) Производное фенила